{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-004249","form_type":"8-K","ticker":"XLO","cik":"0001840233","company_name":"Xilio Therapeutics, Inc.","filed_at":"2024-03-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.908415+00:00","generated_at":"2026-06-04T06:32:38.035479+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Xilio Therapeutics issues 6.86M shares to Gilead at $1.97/share for $13.5M private placement","bullets":["Closed private placement of 6,860,223 shares to Gilead Sciences at $1.97/share for ~$13.5M.","Shares issued under an exclusive license agreement previously disclosed.","Shares outstanding increased from 27,613,263 to 34,473,486.","Placement closed on March 28, 2024, as part of strategic collaboration with Gilead."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-004249","json":"https://secwatch.observer/filing/0001558370-24-004249.json","markdown":"https://secwatch.observer/filing/0001558370-24-004249.md","text":"https://secwatch.observer/filing/0001558370-24-004249.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840233/000155837024004249/0001558370-24-004249-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840233/000155837024004249/xlo-20240328x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T06:32:38.035479+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}